|
    ABBV U.S.: NYSE
    ABBVUS
    After Hours
    Back To Top
    Last Updated: Jul 26, 2021 7:27 p.m. EDT Delayed quote

    $ 117.79

    0.00 0.00%
    After Hours Volume: 102.6K
    Close Chg Chg %
    $117.79 -0.40 -0.34%
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 3.73M 65 Day Avg: 6.3M
    59% vs Avg
    117.27 Day Range 118.47
    79.11 52 Week Range 118.67

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABBV Overview

    Performance

    5 Day
    • 2.05%
    1 Month
    • 4.24%
    3 Month
    • 5.75%
    YTD
    • 9.93%
    1 Year
    • 21.23%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 23 Full Ratings

    Recent News

    • eLesor
    • Dow Jones
    Read full story

    AbbVie Inc. stock underperforms Monday when compared to competitors

    AbbVie Eye Drug AGN-190584 Meets Endpoints in Phase 3 Study

    Read full story

    Musk Tweets That Tesla Will Share Its Charging Network. Why That’s a Savvy Move.

    Read full story

    AbbVie Inc. stock rises Friday, still underperforms market

    AbbVie Gets FDA OK for Pediatric Skin Infection Drug

    Read full story

    AbbVie Inc. stock rises Thursday, outperforms market

    Read full story

    States Unveil $26 Billion Settlement Over Opioid Lawsuits

    Read full story

    AbbVie Inc. stock rises Wednesday, still underperforms market

    Read full story

    AbbVie Inc. stock rises Tuesday, still underperforms market

    Read full story

    AbbVie Inc. stock falls Monday, underperforms market

    Read full story

    19 dividend stocks to help you combat inflation

    Read full story

    AbbVie Inc. stock rises Friday, outperforms market

    AbbVie Says FDA Didn't Meet Action Date for Dermatitis Treatment Application

    Read full story

    AbbVie Inc. stock falls Thursday, still outperforms market

    Read full story

    AbbVie Inc. stock rises Wednesday, outperforms market

    Read full story

    AbbVie Inc. stock outperforms market on strong trading day

    Read full story

    AbbVie Inc. stock outperforms market on strong trading day

    Read full story

    AbbVie Inc. stock rises Friday, still underperforms market

    Read full story

    AbbVie Inc. stock outperforms market despite losses on the day

    Read full story

    AbbVie Inc. stock outperforms market on strong trading day

    • Other News
    • Press Releases

    AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know

    on Zacks.com

    What's in the Cards for AstraZeneca (AZN) in Q2 Earnings?

    on Zacks.com

    The Smartest Dividend Aristocrats to Buy With $500 Right Now

    on Motley Fool

    3 Dividend Stocks to Buy Hand Over Fist If the Market Crashes

    on Motley Fool

    3 Value Stocks to Buy for the Second Half of 2021

    on Motley Fool

    Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?

    on Zacks.com

    AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    on Zacks.com

    Why AbbVie (ABBV) Could Beat Earnings Estimates Again

    on Zacks.com

    Pharma Stock Roundup: JNJ, NVS Q2 Earnings, PFE, ABBV, LLY & MRK FDA Updates

    on Zacks.com

    Healthcare ETFs in Focus as Q2 Earnings Unfold

    on Zacks.com

    Roche's (RHHBY) 1H21 Sales Rise Despite Impact of Biosimilars

    on Zacks.com

    Pfizer (PFE) Inks Vaccine Deal, Faces FDA Delay on JAK Drugs

    on Zacks.com

    3 Biotechs That Could Make Big Acquisitions This Year

    on Motley Fool

    Why AbbVie (ABBV) is a Great Dividend Stock Right Now

    on Zacks.com

    Here's Why AbbVie (ABBV) is a Strong Momentum Stock

    on Zacks.com

    AbbVie (ABBV) Venclexta Gets Breakthrough Therapy Tag for MDS

    on Zacks.com

    Ardelyx (ARDX) Tumbles Following Deficiencies in Tenapanor NDA

    on Zacks.com

    J&J (JNJ) Beats on Q2 Earnings & Sales, Ups View, Stock Rises

    on Zacks.com

    Jim Cramer’s Earnings Season Winners

    on 247WallSt.com

    5 Highest Yielding Dividend Aristocrat Stocks to Buy Now as Interest Rates Continue to Plunge

    on 247WallSt.com

    AbbVie Inc.

    AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson 0.05% $452.39B
    Pfizer Inc. 0.31% $233.31B
    Novo Nordisk A/S Series B -1.73% kr.1.3T
    AstraZeneca PLC -2.22% £131.37B
    AstraZeneca PLC ADR 0.00% $180.65B
    Amgen Inc. -1.07% $142.33B
    Moderna Inc. -3.72% $140.06B
    CSL Ltd. -0.26% $133.57B
    Gilead Sciences Inc. -0.39% $86.56B
    Regeneron Pharmaceuticals Inc. -1.46% $62.47B
    Competitor Data Provided ByCapital Cube Logo